Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial

It is not known whether iron depletion before pegylated IFN or combination treatment improves sustained virological response (SVR) rate in patients with chronic hepatitis C, despite its use in clinical practice in this setting. We aimed to investigate whether blood letting improves the efficacy (SVR...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical apheresis 2009, Vol.24 (5), p.190-196
Hauptverfasser:	Gentile, Ivan, Viola, Chiara, Paesano, Luigi, D'Onofrio, Marcello, D'Agostino, Elio, Cerini, Raimondo, Borrelli, Francesco, Piazza, Marcello, Borgia, Guglielmo
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - administration & dosage Antiviral Agents - adverse effects blood letting Female ferritin Ferritins - blood Hepatitis C, Chronic - blood Hepatitis C, Chronic - therapy Humans Interferon-alpha - administration & dosage Interferon-alpha - adverse effects iron Iron - blood Male Middle Aged pegylated-interferon Phlebotomy Pilot Projects Polyethylene Glycols - administration & dosage Polyethylene Glycols - adverse effects Recombinant Proteins ribavirin Ribavirin - administration & dosage Ribavirin - adverse effects Transferrin - analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!